2016
DOI: 10.1002/mus.24942
|View full text |Cite
|
Sign up to set email alerts
|

Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease

Abstract: In the elderly, IVIg infusions are safe. Adverse reactions mainly depend on IVIg preparation and administration. Renal failure is not uncommon with sugar-free IVIg.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
31
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(33 citation statements)
references
References 44 publications
(133 reference statements)
2
31
0
Order By: Relevance
“…In particular, the likelihood of ARs to IVIG correlated with having neuromuscular diseases (odds: 6.914) among patients with any autoimmune disease. In fact, in that subgroup, the incidence of ARs for neuromuscular diseases was 28.4% (data not shown), consistent with other studies ( 12 , 14 , 21 ) that have reported ARs in more than 20% of patients with neuromuscular diseases. Wietek et al ( 22 ) analyzed data from 112 patients with ITP receiving IVIG, in which there were five cases with at least one AR.…”
Section: Discussionsupporting
confidence: 91%
“…In particular, the likelihood of ARs to IVIG correlated with having neuromuscular diseases (odds: 6.914) among patients with any autoimmune disease. In fact, in that subgroup, the incidence of ARs for neuromuscular diseases was 28.4% (data not shown), consistent with other studies ( 12 , 14 , 21 ) that have reported ARs in more than 20% of patients with neuromuscular diseases. Wietek et al ( 22 ) analyzed data from 112 patients with ITP receiving IVIG, in which there were five cases with at least one AR.…”
Section: Discussionsupporting
confidence: 91%
“…In a parallel-group RCT involving 27 participants, there was no significant difference in efficacy or side-effect profile of two different brands of IVIg (Kuitwaard 2010). In a retrospective review of 244 people with neurological conditions, of whom the majority were older than 60 years, the rate of adverse effects with IVIg was 35% (Lozeron 2016). Most of these adverse effects were transient hypertension and headache, but acute renal dysfunction and venous thrombosis occurred in 2%.…”
Section: Discussionmentioning
confidence: 99%
“…The mechanism is likely osmotic nephrosis, where tubular cells absorb the large sugar load, become vacuolated, swell, and develop tubular nephropathy [83] . This can be minimized through the selection of sucrose-free IVIG if available and if not, infusion of the product at ≤3 mg sucrose/kg/min or use of lower concentrated product (ie, 5%), dividing the dose to 500 mg/kg/day [84] . Case reports suggest that IVIG-induced hemolysis from a sucrose-free IVIG product led to pigment-induced nephropathy and may be an unrecognized cause of acute kidney injury as well [85] .…”
Section: The Use Of Plasma Transfusion For Treating Patients With Hemmentioning
confidence: 99%